Baisios
Fengtai, Beijing, China
About Baisios
Baisios is a developer of tumor immune cell therapy technology and is dedicated to the growth of the tumor biotherapy industry.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Funding stage: Early Stage Venture
- Last round: Series B (Nov 2023)
- Website: bioon.com.cn
- Phone: 010-83682606
Industries & Categories
Biotechnology, Genetics, Medical
Canonical: https://fsome.com/organization/baisios-2491573 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.